Content area

Abstract

Methotrexate is an antimetabolic agent with proliferative and immunosuppressive activity. It has been demonstrated to be an effective treatment for acute lymphoblastic leukemia (ALL) in children. However, there is evidence of an association between methotrexate and toxicity risks, which influences the personalization of treatment, particularly in the case of childhood ALL. This article presents the development and implementation of an algorithm based on artificial neural networks to detect methotrexate toxicity in pediatric patients with acute lymphoblastic leukemia. The algorithm utilizes historical clinical and laboratory data, with an effectiveness of 99% in the tests performed with the patient dataset. The use of neural networks in medicine is often linked to disease diagnosis systems. However, neural networks are not only capable of recognizing examples but also hold very important information. For this reason, one of the main areas of application of neural networks is the interpretation of medical data. In this article, we diagnose, with the application of neural networks in medicine, a concrete example: detecting methotrexate in its early stages in pediatric patients.

Details

1009240
Title
Detecting Methotrexate in Pediatric Patients Using Artificial Neural Networks
Author
Alejandro Medina Santiago 1   VIAFID ORCID Logo  ; Bermúdez Rodríguez, Jorge Iván 2   VIAFID ORCID Logo  ; Orozco Torres, Jorge Antonio 2   VIAFID ORCID Logo  ; Guzmán Rabasa, Julio Alberto 3   VIAFID ORCID Logo  ; Villegas Izaguirre, José Manuel 4   VIAFID ORCID Logo  ; Gladys Falconi Alejandro 5   VIAFID ORCID Logo 

 Instituto Nacional de Astrofísica, Óptica y Electrónica, Coordinación de Ciencias Computacionales—Conahcyt, Santa María Tonanzintla, San Andres Cholula, Puebla 72840, Mexico; Universidad de Ciencia y Tecnología Descartes, Avenida Ciprés 480, Tuxtla Gutiérrez 29065, Mexico; [email protected] 
 Universidad de Ciencia y Tecnología Descartes, Avenida Ciprés 480, Tuxtla Gutiérrez 29065, Mexico; [email protected]; Tecnológico Nacional de México, Instituto Tecnológico de Tuxtla Gutiérrez, Carretera Panamericana Km. 1080, Tuxtla Gutiérrez 29050, Mexico 
 Tecnológico Nacional de México, IT Hermosillo, Av. Tecnológico y Periférico Poniente S/N, Hermosillo 83170, Mexico; [email protected] 
 Facultad de Ciencias de la Ingeniería y Tecnología, Universidad Autónoma de Baja California, Boulevard Universitario #1000, Unidad Valle de las Palmas, Tijuana 21500, Mexico; [email protected] 
 Secretaria Académica, Universidad Politécnica del Golfo de México, Carretera Federal Malpaso—El Bellote Km. 171 / Monte Adentro, Paraíso, Tabasco 86600, Mexico; [email protected] 
Publication title
Volume
15
Issue
1
First page
306
Publication year
2025
Publication date
2025
Publisher
MDPI AG
Place of publication
Basel
Country of publication
Switzerland
Publication subject
e-ISSN
20763417
Source type
Scholarly Journal
Language of publication
English
Document type
Journal Article
Publication history
 
 
Online publication date
2024-12-31
Milestone dates
2024-05-31 (Received); 2024-12-12 (Accepted)
Publication history
 
 
   First posting date
31 Dec 2024
ProQuest document ID
3153575485
Document URL
https://www.proquest.com/scholarly-journals/detecting-methotrexate-pediatric-patients-using/docview/3153575485/se-2?accountid=208611
Copyright
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Last updated
2025-01-10
Database
ProQuest One Academic